SCHEMBL17295634

SCHEMBL17295634

Cc1ccc(N=C2SC(=Cc3ccc4c(cnn4C)c3)C(=O)N2C2CCCCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 0.53
▸ DYRK3 O43781 3/20 0.46
▸ CLK1 P49759 3/20 0.46
▸ CLK3 P49761 3/20 0.46
▸ DYRK1A Q13627 3/20 0.46
▸ DYRK2 Q92630 3/20 0.46
▸ CLK4 Q9HAZ1 3/20 0.46
▸ DYRK1B Q9Y463 3/20 0.46
▸ DYRK4 Q9NR20 2/20 0.46
▸ CLK2 P49760 2/20 0.46
▸ S1PR1 P21453 3/20 0.45
▸ S1PR3 Q99500 1/20 0.45
▸ ESRRA P11474 3/20 0.40
▸ HSD17B3 P37058 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295633 1.00 FAAH (0.53) FAAHDYRK3CLK1CLK3DYRK1A
SCHEMBL17295536 0.92 FAAH (0.52) FAAHDYRK3CLK1CLK3DYRK1A
SCHEMBL17295534 0.92 FAAH (0.52) FAAHDYRK3CLK1CLK3DYRK1A
SCHEMBL17295402 0.81 ALDH1A1 (0.49) FAAHCLK1DYRK1ACLK4DYRK1B
SCHEMBL17295401 0.81 ALDH1A1 (0.49) FAAHCLK1DYRK1ACLK4DYRK1B
SCHEMBL19096243 0.79 FAAH (0.56) FAAHDYRK1ADYRK2DYRK1BS1PR1
SCHEMBL17295567 0.78 FAAH (0.54) FAAHDYRK3CLK1CLK3DYRK1A
SCHEMBL17295564 0.78 FAAH (0.54) FAAHDYRK3CLK1CLK3DYRK1A
SCHEMBL17295605 0.78 FAAH (0.55) FAAHS1PR1S1PR3ALDH1A1POLB
SCHEMBL17295607 0.78 FAAH (0.55) FAAHS1PR1S1PR3ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback